Recruitment Messages for Current Smokers Recently Diagnosed With Cancer
NCT ID: NCT05471284
Last Updated: 2022-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
99 participants
INTERVENTIONAL
2019-02-11
2019-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gain-framed Messages and NRT for Lung Cancer Screening Patients
NCT03069924
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
NCT05008848
Tobacco Treatment in the Context of Lung Cancer Screening
NCT03927989
Mobile-based Peer Mentoring for Smoking Cessation
NCT03048786
Young Adults' Responses to Anti-smoking Messages
NCT01954407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: This study aims to identify the message frames that were most effective in promoting intent to talk to a physician about participating in a tobacco treatment trial for smokers recently diagnosed with cancer.
Methods: From February to April 2019, current smokers diagnosed within the past 24 months were recruited from a national web-based panel for a multimethod pilot randomized trial (N=99). Participants were randomized to a 2×3 plus control factorial design that tested 3 unique message frames: proximal versus distal threats of smoking, costs of continued smoking versus benefits of quitting, and gains of participating versus losses of not participating in a tobacco treatment trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control condition was a kernel message that included study information present in all conditions but did not include any of the message factors.
Control
Does not include any of the three message factors.
Proximal x Cost x Loss
Message frame: proximal threats of smoking, cost of continued smoking, and loss of not participating in a tobacco treatment trial.
Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Proximal x Cost x Gain
Message frame: proximal threats of smoking, cost of continued smoking, and gain of participating in a tobacco treatment trial.
Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Proximal x Benefit x Gain
Message frame: proximal threats of smoking, benefits of quitting, and gain of participating in a tobacco treatment trial.
Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Proximal x Benefit x Loss
Message frame: proximal threats of smoking, benefits of quitting, and loss of not participating in a tobacco treatment trial.
Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Distal x Cost x Gain
Message frame: distal threats of smoking, cost of continued smoking, and gain of participating in a tobacco treatment trial.
Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Distal x Cost x Loss
Message frame: distal threats of smoking, cost of continued smoking, and loss of not participating in a tobacco treatment trial.
Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Distal x Benefit x Loss
Message frame: distal threats of smoking, benefits of quitting, and loss of not participating in a tobacco treatment trial.
Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Distal x Benefit x Gain
Message frame: distal threats of smoking, benefits of quitting, and gain of participating in a tobacco treatment trial.
Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Control
Does not include any of the three message factors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A recent cancer diagnosis (within the past 24 months)
* 18 years or older
* Report any cigarette use within the past 30 days
Exclusion Criteria
* Have not been diagnosed with cancer within the past 24 months
* Below the age of 18
* Does not report any cigarette use within the past 30 days
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts University
OTHER
Massachusetts General Hospital
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
University of Oklahoma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jordan Neil, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
TSET Health Promotion Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jordan Neil
Oklahoma City, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Neil JM, Senecal C, Ballini L, Chang Y, Goshe B, Flores E, Ostroff JS, Park ER. A Multimethod Evaluation of Tobacco Treatment Trial Recruitment Messages for Current Smokers Recently Diagnosed With Cancer: Pilot Factorial Randomized Controlled Trial. JMIR Cancer. 2022 Aug 24;8(3):e37526. doi: 10.2196/37526.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018P002035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.